Sun Mountain Capital is an investment partnership formed by senior private equity professionals based in Santa Fe, New Mexico.
Business Model: Consulting
Revenue: $8.7M
Employees: 11-50
Address: 301 Griffin St
City: Santa Fe
State: NM
Zip: 87501
Country: US
Sun Mountain Capital is an investment partnership formed by senior private equity professionals based in Santa Fe, New Mexico. The Firm’s professionals have a depth of experience in private equity that dates back to 1981 and have an extensive track record of creating value through fund advisory activities and direct investments in promising companies. Prior experience for the principals include employment at Credit Suisse First Boston, Morgan Stanley, Brentwood Associates, Fort Washington Investment Advisors, GE Capital, Kline Hawkes, and The Boston Consulting Group, among other top tier firms. As a private equity advisor to pension plans and other program sponsors, Sun Mountain develops customized private equity programs. They analyze key success factors across numerous private equity programs and then use the information to develop solutions tailored to meet the specific investment goals of the program.
Contact Phone:
+15059545474
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2011 | Exagen | Venture Round | 12M |
4/2020 | BennuBio | Series B | 0 |
8/2017 | Armonica | Seed Round | 0 |
5/2017 | TriLumina Corp. | Venture Round | 9M |
6/2010 | Simpleview Book › Direct | Venture Round | 1.3M |
1/2008 | Lumidigm | Series C | 0 |
4/2018 | BayoTech | Series B | 12.5M |
2/2015 | TriLumina Corp. | Series B | - |
3/2012 | Comet Solutions | Series C | 4M |
9/2018 | BennuBio | Series A | 0 |
10/2021 | Armonica | Series B | 0 |
5/2011 | Exagen | Venture Round | 5.4M |
2/2011 | Exagen | Venture Round | 16.9M |
11/2013 | Exagen | Debt Financing | 25M |
5/2018 | Agilvax | Series A | 500k |
12/2015 | Seamless Medical Systems | Venture Round | 2.5M |
8/2013 | Respira Therapeutics | Series A | 2M |
10/2014 | Aspen Avionics | Venture Round | 2.1M |
1/2015 | Respira Therapeutics | Convertible Note | 600k |
2/2014 | TriLumina Corp. | Series A | - |
10/2014 | Respira Therapeutics | Convertible Note | 1.5M |
7/2014 | Exagen | Debt Financing | 4M |
10/2019 | mPower Technology | Series A | 2.5M |
9/2012 | Exagen | Series C | 5.3M |
8/2013 | xF Technologies | Series A | 2M |
2/2012 | Exagen | Venture Round | 34.1M |
7/2019 | 3d Glass Solutions | Series B | 0 |
8/2017 | Robotic Skies | Seed Round | - |
7/2019 | Exagen | Venture Round | 0 |
1/2021 | First Crop | Series A | 202k |
8/2018 | RiskSense | Series B | 12M |
2/2014 | xF Technologies | Series A | 4.5M |
7/2007 | Aspen Avionics | Series B | 8.5M |
10/2022 | Green Theme Technologies | Series B | 5.4M |
10/2012 | Aspen Avionics | Series C | 0 |
12/2020 | UbiQD | Series A | 0 |
7/2014 | xF Technologies | Debt Financing | 3M |
3/2017 | RiskSense | Series A | 0 |
1/2021 | BayoTech | Private Equity Round | 157M |
6/2007 | Advent Solar | Series D | 0 |
6/2019 | Robotic Skies | Series A | - |
1/2013 | TriLumina Corp. | Series A | - |
7/2014 | SBA Materials | Series C | - |
12/2015 | SBA Materials | Series D | - |
6/2008 | nanoMR | Series A | 5.5M |
9/2022 | Vega Cloud | Venture Round | 0 |
1/2022 | 3d Glass Solutions | Series B | 0 |
7/2011 | nanoMR | Series B | 13M |
9/2011 | Skorpios Technologies | Series B | 19M |
1/2022 | 3d Glass Solutions | Series B | 0 |
10/2021 | Armonica | Series B | 0 |
1/2021 | BayoTech | Series C | 0 |
1/2021 | First Crop | Series A | 0 |
12/2020 | UbiQD | Series A | 0 |
4/2020 | BennuBio | Series B | 0 |
10/2019 | mPower Technology | Series A | 0 |
7/2019 | Exagen | Venture Round | 0 |
7/2019 | 3d Glass Solutions | Series B | 0 |
6/2019 | Robotic Skies | Series A | - |
Name | Price |
---|
Name | Size | Announced Date |
---|